Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK  by Wu, Defeng & Cederbaum, Arthur I.
Research Paper
Inhibition of autophagy promotes CYP2E1-dependent toxicity
in HepG2 cells via elevated oxidative stress, mitochondria dysfunction
and activation of p38 and JNK MAPK
Defeng Wu, Arthur I. Cederbaum n
Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, Box 1603, One Gustave L. Levy Place, New York, NY 10029,
USA
a r t i c l e i n f o
Article history:
Received 23 October 2013
Accepted 27 October 2013
Keywords:
CYP2E1
Autophagy
P38 MAPK
JNK
Mitochondria dysfunction
ROS
Cytotoxicity
a b s t r a c t
Autophagy has been shown to be protective against drug and alcohol-induced liver injury. CYP2E1 plays
a role in the toxicity of ethanol, carcinogens and certain drugs. Inhibition of autophagy increased
ethanol-toxicity and accumulation of fat in wild type and CYP2E1 knockin mice but not in CYP2E1
knockout mice as well as in HepG2 cells expressing CYP2E1 (E47 cells) but not HepG2 cells lacking
CYP2E1 (C34 cells). The goal of the current study was to evaluate whether modulation of autophagy can
affect CYP2E1-dependent cytotoxicity in the E47 cells. The agents used to promote CYP2E1 –dependent
toxicity were a polyunsaturated fatty acid, arachidonic acid (AA), buthionine sulfoximine (BSO), which
depletes GSH, and CCl4, which is metabolized to the CCl3 radical. These three agents produced a decrease
in E47 cell viability which was enhanced upon inhibition of autophagy by 3-methyladenine (3-MA) or
Atg 7 siRNA. Toxicity was lowered by rapamycin which increased autophagy and was much lower to the
C34 cells which do not express CYP2E1. Toxicity was mainly necrotic and was associated with an increase
in reactive oxygen production and oxidative stress; 3-MA increased while rapamycin blunted the
oxidative stress. The enhanced toxicity and ROS formation produced when autophagy was inhibited was
prevented by the antioxidant N-Acetyl cysteine. AA, BSO and CCl4 produced mitochondrial dysfunction,
lowered cellular ATP levels and elevated mitochondrial production of ROS. This mitochondrial dysfunc-
tion was enhanced by inhibition of autophagy with 3-MA but decreased when autophagy was increased
by rapamycin. The mitogen activated protein kinases p38 MAPK and JNK were activated by AA especially
when autophagy was inhibited and chemical inhibitors of p38 MAPK and JNK lowered the elevated
toxicity of AA produced by 3-MA. These results show that autophagy was protective against the toxicity
produced by several agents known to be activated by CYP2E1. Since CYP2E1 plays an important role in
the toxicity of ethanol, drugs and carcinogens and is activated under various pathophysiological
conditions such as diabetes, NASH and obesity, attempts to stimulate autophagy may be beneﬁcial in
preventing/lowering CYP2E1/ethanol liver injury.
& 2013 The Authors. Published by Elsevier B.V.
Introduction
Autophagy is an intracellular pathway by which lysosomes
degrade and recycle long-lived proteins and cellular organelles.
This pathway degrades cellular components that are worn out or
damaged or are needed to generate substrates that maintain
cellular energy homeostasis under conditions of limited nutrients
or stress [1–3]. The regulation of autophagy is complex and
controlled by the coordinated actions of autophagy-related genes.
A key regulator of autophagy is the mammalian target of rapamycin
(mTOR) which senses cellular nutritional status and cell stress [4,5].
Removal of damaged mitochondria by mitophagy or of lipid
droplets by lipophagy are selective forms of macroautophagy
[6–11]. Removal of damaged mitochondria protects the cell against
mitochondrial oxidative stress, while removal of lipid droplets
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limits the accumulation of lipids by hepatocytes. Defects in
lipophagy can contribute to hepatic steatosis [10,11]. Autophagy
is decreased in certain hepatic and pancreatic diseases e.g.
α1-antitrypsin deﬁciency and non-alcoholic fatty liver disease,
but increased in nutrient deﬁciency and hepatitis B infection
[7,12]. In general, autophagy is considered as a cell survival
pathway but one that can also mediate cell death under certain
conditions or when over activated. Recent studies showed that
autophagy protects cells against injury from alcohol, because
chemical and genetic inhibition of autophagy increased the levels
of injury in cultured hepatocytes and mouse liver [6,13–15].
CYP2E1 metabolizes and activates many toxicological impor-
tant substrates including ethanol, to more toxic products [16–20].
CYP2E1 generates reactive oxygen radical species during its
catalytic cycle and is induced by ethanol. [21–23]. Ethanol-
induced liver pathology has been shown to correlate with CYP2E1
levels and lipid peroxidation [24–27]. Inhibitors of CYP2E1 pre-
vented the elevation of lipid peroxidation and the ethanol-induced
liver pathology [28,29]. The biochemical and toxicological proper-
ties of CYP2E1 have been studied in Rala hepatocytes [30], in
HepG2 cell lines [31–33], in transgenic mice [34] and in mice
infected with adenovirus expressing CYP2E1 [35]. CYP2E1 has
been shown to contribute to ethanol-induced steatosis [36].
Autophagy can modulate CYP2E1-dependent ethanol toxicity
in vitro and in vivo as inhibition of autophagy increased binge
ethanol-induced steatosis in wild type and CYP2E1 knockin mice
but not CYP2E1 knockout mice and increased ethanol-induced fat
accumulation in E47 HepG2 cells which express CYP2E1 but not in
C34 HepG2 cells which do not express CYP2E1 [37–39]. The
rationale for these and the current study is that CYP2E1 plays a
role in ethanol-induced oxidant stress, fatty liver and liver injury.
Autophagy, in some settings is protective against cell injury, while
in other settings, autophagy can promote cell toxicity. If autophagy
is protective against ethanol/CYP2E1 toxicity, attempts to stimu-
late autophagy may prove to be helpful in lowering ethanol-/
CYP2E1 induced liver injury. If autophagy promotes ethanol/
CYP2E1 toxicity, inhibitors of autophagy may help to ameliorate
this hepatotoxicity. In the current study we evaluated whether
modulation of autophagy can affect CYP2E1 –dependent cytotoxi-
city in the E47 cells. Toxins used to promote toxicity included CCl4,
which is activated by CYP2E1 to reactive intermediates [40],
arachidonic acid as a representative polyunsaturated fatty acid
which promotes ethanol-induced liver injury [25,28], and BSO
which lowers GSH levels and impairs cellular antioxidant defense
[41]. All three of these compounds have previously been shown to
be toxic to the E47 cells but not to C34 cells [33,42] but the effects
of autophagy on their toxicity has not been determined.
Previous studies, in the absence of modulation of autophagy,
showed that activation of p38 MAPK played a role in AA, BSO and
TNFα-induced toxicity to E47 cells [43–45]. JNK MAPK has been
implicated in many models of chemical and drug-induced liver
toxicity [46–51] and in binge ethanol-induced steatosis [38].
Induction of autophagy by free fatty acids was JNK-dependent
[52]. These results suggest possible cross talk between autophagy
and MAPK. A second goal of this study was to determine whether
activation of MAPK occurs under these experimental conditions
and whether MAPK play a role in the autophagy-modulated
toxicity of AA, BSO and CCL4.
Materials and methods
Cell model and treatment
HepG2 E47 cells which express human CYP2E1 and control
HepG2 C34 cells which do not express CYP2E1 [53] were treated
with either 20 or 45 mMAA [43], or 300 mM BSO [41,44], or 300 mg/ml
CCl4 [54] in the presence or absence of 3-MA (2.5 mM, Sigma), or
rapacycin (0.2 mg/ml, LC Laboratories, MA) for 24 or 48 h respec-
tively. The medium was replaced every 24 h with fresh reagents.
Cell viability was determined by a MTT assay [53]. Cell morphology
was observed under an inverted light contrast microscope. To
determine the percentage of cells undergoing necrosis or apoptosis
in the total cell population, 2106 cells were harvested with
trypsin and resuspended in 3 ml 1 PBS, and stained with
0.25 mg/ml annexin V and 1 mg/ml PI for 10 min. The percentage
of cells undergoing necrosis and apoptosis was determined by ﬂow
cytometry according to the annexin V or PI positive cell staining.
Cells after double staining were also observed under a ﬂuorescence
microscope.
Knockdown of Atg 7
Autophagy was blocked by knockdown of Atg 7 with Atg 7 siRNA.
E47 cells, 5105/well, were seeded into a 12 well plate with 1 ml
medium and incubated overnight. Mediumwithout serum, contain-
ing 25 nM Atg 7 siRNA, or scrambled siRNA (Cell Signaling) was
mixed with 5ul transfection reagent for 30 min at room tempera-
ture and then added to the cells. The ﬁnal volume was adjusted
with medium to 0.5 ml per well and the mixture was incubated for
48 h. Cells were harvested and assays were carried out to evaluate
Atg 7 content, cytotoxicity and ROS production.
ROS stress
ROS stress was evaluated by measuring lipid peroxidation
(TBARS) and levels of GSH [41,43,44]. Cells were also incubated
with 5 mM 2′-7′-dichloroﬂuorescin-diacetate (DCFDA, SERVA) for
10 min and green ﬂuorescence was observed under a ﬂuorescence
microscope. Cells were also re-suspended in 1 PBS and the
ﬂuorescence was determined in a Perkin-Elmer ﬂuorescence
spectrophotometer at Ex488/Em530 nm. To evaluate ROS stress
in the mitochondria, at the end of treatment cells were incubated
with 5 mM Mitosox (Molecular Probes) as previously described
[48] for 10 min and red ﬂuorescence of the stained mitochondria
was observed under a ﬂuorescence microscope. The cells were
also re-suspended in 1PBS and the intensity of ﬂuorescence
was determined in the ﬂuorescence spectrophotometer at Ex510/
Em580 nm.
Autophagy evaluation
The modulation of autophagy by AA, BSO and CCl4 in the
absence and presence of 3-MA or rapamycin was evaluated by
immunoblots to determine the levels of LC3-Il and LC3-I (antibody
from Thermo), the ratio of LC3-II/LC3-I and levels of autophagy
regulatory proteins p62 and Beclin-1 (antibodies from Santa Cruz).
Immunoblots were scanned and analyzed as the p62/β-actin or the
Beclin-1/β-actin ratios using a LI-COR Odyssey densitometer and
software Image J from NIH.
Mitochondrial dysfunction
Mitochondria membrane swelling
Cells were homogenized by 30 strokes with a glass Pyrex micro
homogenizer. Fresh mitochondria were prepared by differential
centrifugation in a buffer containing 0.25 M sucrose, 10 mM Tris–
HCl, pH 7.4. Calcium-induced mitochondrial swelling was assayed
as an index of the mitochondrial permeability transition [55,56]. In
a 1 ml cuvette, 500 mg mitochondria protein was added into 1 ml
of buffer containing 150 mM KCl, 10 mM Tris–MOPS, pH 7.4, 5 mM
glutamic acid, 2.5 mM malic acid and 1 mM KPi. CaCl2 was added
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(100 mM ﬁnal concentration) to trigger swelling which was
recorded from the decrease in absorbance at 540 nm.
ATP levels
ATP levels were measured using the ATP Determination Kit
(Molecular Probes, A22066). In the presence of ATP, luciferin and
luciferase, the products oxyluciferin, AMP and light, are produced.
The light was detected in a chemiluminescence detector and ATP
levels were compared to a standard curve with ATP.
Cytochrome c release
The post mitochondrial supernatant was collected after homo-
genates were centrifuged at 8000g. Immunoblots were carried out
to detect for the presence of cytochrome c in the cytosol fraction.
To ensure the cytosol preparation was not contaminated with
mitochondria, immunoblots were carried out to determine
whether mitochondrial SOD2 was present in the cytosol Cyto-
chrome c in the mitochondrial fraction was also determined by
immunoblot.
Activation of p38 MAP kinase and JNK
E47 cells were treated with 20 mM AA in the presence and
absence of 3-MA or rapamycin for 6, 12, 24 and 48 h. Cell lysates
were collected and immunoblots were carried out to detect levels
of pp38 MAPK, p38 MAPK, pJNK and JNK [38,43,44] (antibodies
from Santa Cruz). Results are presented as the ratios of pp38
MAPK/p38 MAPK or pJNK/JNK. To evaluate whether the activation
of p38 MAPK or JNK contribute to cytotoxicity, E47 cells were
treated with 3-MA plus AA in the presence or absence of the p38
MAPK inhibitor SB203580 (5 mM, BioChem), or JNK inhibitor
SP600125 (2.5 mM, BioChem), and cell viability determined by a
MTT assay. Levels of pp38 and pJNK MAPK after treatment with
the inhibitors were determined to validate their inhibitory effects.
Statistical analysis
Statistical analysis was performed using one-way analysis of
variance with subsequent post hoc comparisons by Scheffe. Values
reﬂect means7standard error. The number of experiments is
indicated in the ﬁgure legends.
Results
Inhibition of autophagy enhances CYP2E1-dependent AA, BSO and
CCl4 cytotoxicity
To study whether autophagy promotes or protects against
CYP2E1-mediated AA or BSO or CCl4 induced cytotoxicity, HepG2
E47 and C34 cells were treated with these compounds in the
presence or absence of 3-MA or rapamycin to inhibit or induce
autophagy, respectively. During the ﬁrst 24 h of treatment, there
was little or no toxicity to both cells lines by the various additions
(data not shown). After 48 h of treatment, AA, BSO and CCl4
induced some toxicity in E47 cells but not in C34 cells (Fig. 1A).
Inhibition of autophagy by 3-MA, signiﬁcantly increased the
toxicity of AA, BSO, and CCl4, whereas the induction of autophagy
with rapamycin protected against this toxicity (Fig. 1A). Morpho-
logical observations also supported the potentiation of AA, BSO or
CCl4 toxicity by 3-MA (Fig. 1B). Increases in cytotoxicity were
found in E47 but not in C34 cells (Fig. 1A), suggesting that CYP2E1
plays a role in the 3-MA-potentiation of toxicity. To assess the
mode of cell death, the E47 cells were incubated with AA or BSO or
CCl4 in the absence and presence of 3-MA or rapamycin for 48 h,
stained with annexin V and PI and analyzed by ﬂow cytometry to
determine the percentage of cells undergoing apoptosis and
necrosis. The inhibition of cell autophagy with 3-MA primarily
enhanced AA-, BSO-, and CCl4-induced necrosis (from 12–17% in
the absence of 3-MA to 30–33% in the presence of 3-MA) (Fig. 1C).
There was also a small increase in apoptosis produced by 3-MA
(from 6-8% in the absence of 3-MA to 9–15% in the presence of
3-MA) (Fig. 1C). Rapamycin reduced the necrosis produced by AA,
BSO and CCl4 (from 12–17% to 7–9%) but either had no effect (BSO)
or slightly increased (AA, CCL4) apoptosis. Incubation of the E47
cells with AA resulted in some PI positive-staining cells over the
no addition control (Fig. 1D). Treatment with 3-MA increased
while incubation with rapamycin decreased the PI-positive-
staining cells (Fig. 1D). Annexin V staining was low after AA
incubation and was only slightly increased by 3-MA. Thus, cell
death was primarily necrotic.
Inhibition of autophagy promotes ROS stress
The inhibition of autophagy with 3-MA in the E47 cells
promoted AA, BSO or CCl4 induced ROS stress. Lipid peroxidation,
assessed as formation of TBARs was increased by AA or BSO or CCl4
(Fig. 2). Treatment with 3-MA further elevated the level of TBARs
whereas rapamycin decreased these levels (Fig. 2A). E47 cellular
levels of GSH were decreased by AA or BSO or CCl4 (Fig. 2B).
Inhibition of autophagy with 3-MA resulted in a further decline in
GSH levels, whereas rapamycin either had no effect or increased
GSH levels (Fig. 2B).
Inhibition of autophagy by knockdown of Atg 7
siRNA against Atg 7 was used as a genetic approach to decrease
autophagy. E47 cells were incubated with Atg 7 siRNA or control
scrambled siRNA for 48 h and levels of Atg 7 determined. When
used at a ﬁnal concentration of 25 nM, levels of Atg 7 were
lowered by more than 90% as compared to the treatment with
control siRNA (Fig. 3A). E47 cells were ﬁrst incubated with Atg 7
(or control) siRNA for 48 h, AA was added and cell viability was
assayed after 48 h incubation with AA. The knockdown of autop-
hagy with Atg 7 siRNA signiﬁcantly increased AA toxicity from a
decline in cell viability of 38% in the absence of the Atg 7 siRNA to
a decline of 62% in the presence of Atg 7 siRNA (Fig. 3B). The
control siRNA had no effect on AA toxicity, whereas rapamycin
afforded protection (decline in viability of 18% by AA) (Fig. 3B).
To evaluate whether increases in oxidative stress play a role in
the increase in toxicity when autophagy is inhibited, the ability of
the antioxidant NAC to protect against the AA-induced toxicity
was determined. Toxicity by AA was partially prevented by NAC
and importantly, the elevated toxicity of AA in the presence of
Atg 7 siRNA was also blunted by NAC (Fig. 3C). The control siRNA
did not block the AA toxicity but NAC again blocked AA toxicity in
the presence of the control siRNA. ROS production by the E47 cells
was measured using DCFDA as the probe. Incubation with AA
produced an increase in DCF ﬂuorescence (Fig. 3D (a), quantiﬁed in
Fig. 3D (b)). This ﬂuorescence was elevated by the Atg 7 siRNA but
not control siRNA (Fig. 3D). Taken as a whole these results are
supportive of a role for ROS in the potentiation of AA toxicity when
autophagy is inhibited.
3-MA and rapamycin impact autophagy in E47 cells
To study the effect of the added toxins on autophagy and to
validate that the treatment with 3-MA or rapamycin inhibited or
induced autophagy, E47 cells were treated with AA, BSO or CCl4 in
the absence and presence of 3-MA or rapamycin and the LC3-II/
LC3-I ratio was measured along with levels of p62 and Beclin-1.
Treatment with 3-MC alone or rapamycin alone or with AA, BSO or
CCl4 had no effect on the LC3-II/LC3-I ratio but when the 3 toxins
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Fig. 1. Autophagy protects against CYP2E1-mediated AA, CCl4 and BSO cell toxicity. HepG2 E47 and C34 cells were treated with AA (20 mM), CCl4 (300 ug/ml) or BSO
(300 mM) for 48 h in the presence and absence of 3-MA (2.5 mM) or rapamycin (0.2 mg/ml). (A) Cell viability was determined by a MTT assay (*Po0.05 compared with AA or
BSO or CCl4 alone; #Po0.05 compared to the AAþ3-MA or BSOþ 3-MA or CCl4þ3-MA groups; n¼4). (B) Cell morphology was observed under an inverted light contrast
microscope (magniﬁcation 200). (C) E47 cells were treated as described above for 48 h. Cells were harvested with trypsin and resuspended in PBS and then were double
stained with annexin V and PI and analyzed by ﬂow cytometry to determine, the percentage of cells undergoing apoptosis and necrosis (**Po0.05 compared to control;
&Po0.05 compared with AA alone or CCl4 alone group; n, #Po0.05 compared with AA, BSO or CCl4 alone group; N¼3). (D) E47 cells were treated with medium alone
(control) or with AA in the presence or absence of 3-MA or rapamycin for 48 h, cells were stained with Annexin V or PI and were observed under a ﬂuorescence microscope
to determine the apoptosis (Annexin V staining, green ﬂuorescence) and necrosis (PI staining, red ﬂuorescence), (magniﬁcation 200).
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were incubated in the presence of 3-MA, the LC3-II/LC3-I ratio was
decreased by 30–50%, (Fig. 4A). Treatment of the 3 toxins in the
presence of rapamycin produced a 1.6–2.4 fold increase in the
LC3-II/LC3-I ratio compared with AA, BSO or CCl4 alone (Po0.05)
(Fig. 4). Lysosomal degradation of autophagosomes leads to a
decrease in p62/SQSTM1 levels during autophagy and autophagy
inhibitors stabilize and elevate p62/SQSTM1 levels. While AA, BSO,
and CCl4 had no effect on p62 levels in the absence of 3-MA or
rapamycin, p62 levels, were increased when either of the 3 toxins
were incubated in the presence of 3-MA but decreased when
incubated in the presence of rapamycin as compared with incuba-
tion with AA, BSO or CCl4 alone (Fig. 4B). Beclin-1 which regulates
the formation of the autophagosome [1–3] was decreased by
treatment with AA, BSO or CCl4 alone and further decreased when
the toxins were incubated in the presence of 3-MA (Fig. 4C). These
results show that in the E47 cells, incubated with either AA or BSO
or CCl4, 3-MA inhibits, while rapamycin stimulates autophagy.
Neither of the 3 toxins or 3-MA or rapamycin had an effect on
CYP2E protein levels in the E47 cells (Fig. 4D) (or catalytic activity
– data not shown).
Autophagy prevents CYP2E1-promoted mitochondrial dysfunction
Damaged and/or oxidized mitochondria are removed from the
cell by autophagy (mitophagy) [8,11]. Experiments were carried
out to evaluate whether mitochondrial dysfunction occurs when
the 3 toxins are incubated in the E47 cells and how such
dysfunction might be modulated by inhibiting or stimulating
autophagy with 3-MA or rapamycin, respectively. Damage to the
mitochondrial membrane promotes the mitochondrial permeabil-
ity transition (MPT). Calcium-induced mitochondrial membrane
swelling in the presence of glutamate–malate was determined as a
reﬂection of the MPT. Mitochondria from E47 cells treated with
AA, BSO or CCl4 underwent swelling as shown by the decrease in
absorbance at 540 nm (Fig. 5A–C). 3-MA treatment enhanced the
mitochondrial swelling while rapamycin treatment decreased the
swelling (Fig. 5A–C). Cellular levels of ATP were determined as an
index of the cellular energy state and because autophagy requires
ATP [57,58]. Incubation with AA, BSO or CCl4 caused a 30% decline
in ATP levels (Fig. 5D). ATP levels were further lowered to more
than a 50% decline when AA, BSO or CCl4 were incubated in the
presence of 3-MA. (Fig. 5D). Rapamycin had no effect on ATP levels
or the decline in these levels produced by AA or BSO or CCl4.
Mitochondrial membrane swelling and damage may cause cyto-
chrome c release from the mitochondria to the cytosol. While the
treatment with 3-MA or AA or BSO or CCl4 alone had little effect
on cytosolic cytochrome c levels, incubation of the 3 toxins in the
presence of 3-MA elevated cytosolic cytochrome c levels (Fig. 5E).
Under the latter conditions, mitochondrial levels of cytochrome c
were reduced (Fig. 5F), likely a reﬂection of cytochrome c release
from the mitochondria to the cytosol.
Inhibition of autophagy with 3-MA or Atg 7 siRNA increased
the AA- or BSO- or CCl4-induced total cellular ROS formation
(TBARs, GSH, DCFDA ﬂuorescence). We evaluated whether mod-
ulation of autophagy impacts on mitochondrial ROS formation.
The E47 cells were incubated with Mitosox to evaluate mitochon-
drial ROS production. AA or BSO or CCl4 alone increased Mitosox
ﬂuorescence over the buffer control (Fig. 6A). Incubation of the
3 toxins in the presence of 3-MA strikingly increased the red
ﬂuorescence while incubation in the presence of rapamycin
lowered the red staining (Fig. 6A (a), quantiﬁed in Fig. 6A (b)).
Similarly, incubation of the E47 cells with AA plus Atg 7 siRNA, but
not control siRNA, enhanced the Mitosox ﬂuorescence over that
induced by AA alone (Fig. 6B (a), quantiﬁed in Fig. 6B (b)). Both the
AA-induced Mitosox ﬂuorescence and the AA plus Atg 7 siRNA-
enhanced Mitosox ﬂuorescence were blunted by NAC (Fig. 6B).
Activation of p38 MAPK and JNK
p38MAPK was shown to play a role in AA, BSO and TNFα
toxicity in the E47 cells [43–45] while JNK was activated in many
models of liver toxicity and steatosis [38,46–52]. We evaluated
whether activation of p38 MAPK or JNK occurs under these
experimental conditions and if activation of MAPK contributed to
the potentiation of cytotoxicity when autophagy was blocked. AA
alone activated p38MAPK about 2-fold after incubation for 24 and
48 h (Fig. 7A and B). Activation was enhanced to 3–4 fold when AA
was incubated in the presence of 3-MA; there was also an early
activation of p38 MAPK at 6 h (Fig. 7A and B). Rapamycin had no
effect by itself or in the presence of AA or BSO or CCl4 on p38
MAPK activation. JNK was not activated by AA added alone.
However, both JNK1 and JNK2 were activated by the combination
of AA plus 3-MA after incubation for 24 and 48 h (Fig. 7C and D).
To determine if activated p38 MAPK and/or JNK play a role in
the enhanced toxicity when AA is incubated with 3-MA, E47 cells
were treated with a p38 MAPK inhibitor SB203580 (SB) or a JNK
inhibitor SP600125 (SP) for 24 and 48 h. SB and SP partially
prevented the 3-MA enhanced AA toxicity elevating cell viability,
especially at 24 h (Fig. 8A). SB, but not SP, was very effective in
lowering the activation of p38 MAPK produced by AA plus 3-MA to
below basal levels (Fig. 8B and C; lanes 3 and 4) while SP, but not
SB, effectively blocked the 2–3 fold elevated ratio of pJNK1/JNK1 to
below basal levels (Fig. 8D and E: lanes 3 and 5), validating their
speciﬁc inhibitory effectiveness.
Fig. 2. Pharmacological inhibition of autophagy enhances AA, BSO or CCl4 induced
ROS stress. E47 cells were treated with AA, BSO or CCl4 in the presence or absence
of 3-MA or rapamycin for 48 h. (A) Lipid peroxidation was determined by
measuring the formation of TBARs products. (B) GSH levels were determined with
GSH reductase. (&Po0.05 compared with control; n, #Po0.05 compared with AA,
BSO or CCl4 alone, N¼3).
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Discussion
Autophagy can either be increased or decreased by ethanol
depending on the model used, the dose, the tissue evaluated and
the experimental condition [6,7,12–15,37–39,59,60]. While the
effects of ethanol on autophagy are complex and require further
study, it is becoming clear that autophagy serves a protective
function against ethanol-induced liver injury e.g. Ding et al. [13]
showed that autophagy protects against liver injury in an acute
mouse model of binge alcohol consumption. Donohue et al.
proposed that chronic ethanol increases autophagosome forma-
tion but blocks autolysosome formation [14,61]. Chronic ethanol
consumption was recently shown to increase autophagy [15,62]
and in some cases this increase was associated with a decrease in
activity of the other major cellular proteolyic system, the proteo-
some complex [63]. In response to alcohol, the liver might increase
autophagy to selectively eliminate damaged mitochondria and
limit lipid accumulation [15,62]. Indeed, inhibition of autophagy
with chloroquin enhanced acute and chronic ethanol-induced
steatosis and liver injury while stimulation of macroautophagy
with either rapamycin or carbamazepine decreased acute and
chronic ethanol-induced fatty liver [15], results consistent with
autophagy serving a protective role against acute and chronic
ethanol toxicity.
CYP2E1 metabolizes and activates many toxicological impor-
tant substrates [16–20,40]. CYP2E1 plays a role in ethanol-induced
oxidative stress, ethanol-induced hepatotoxcity [21–29] and
ethanol-induced steatosis [36,64]. Understanding the effects of
autophagy on CYP2E1-dependent metabolic and toxicological
actions (promotion or protection) is important for many reasons,
even besides the possible modulation of alcohol-induced liver
injury since CYP2E1 is induced under a variety of pathophysiolo-
gical conditions such as fasting, diabetes, obesity and high fat diet
[65–69], by drugs [18,19,40] and in non alcohol-induced steato-
hepatitis [70,71]. Indeed, inhibition of autophagy potentiated
high fat-induced steatohepatitis [15] and increased toxicity of
acetaminophen, an effective substrate for metabolism by CYP2E1
[72]. Perhaps of major pathophysiological relevance is whether
Fig. 3. Knockdown of Atg 7 promotes AA induced ROS formation and cytotoxicity. (A) Transfection of E47 cells with Atg 7 siRNA but not control siRNA for 48 h lowers levels
of Atg 7. (B) E47 cells were transfected with Atg 7 siRNA or control siRNA for 48 h. Cells were then treated with AA (20 mM) or rapamycin for an additional 48 h and cell
viability determined by a MTT assay. (nPo0.05 compared with control; nnPo0.05 compared with AA alone, N¼3.) (C) NAC (5 mM) was added to evaluate the involvement of
ROS in AA toxicity and the potentiation of this toxicity by Atg 7 siRNA. (nPo0.05 compared with control, #Po0.05 compared with AA alone, $Po0.05 compared with AA
plus Atg 7 siRNA, N¼3), (D) (a), E47 cells were treated as described in (B); DCFDA (5 mM) was added, and after 15 min incubation, ROS-activated ﬂuorescence was detected
under a ﬂuorescence microscope (magniﬁcation 100). (b), Cells were re-suspended in 1PBS and the intensity of ﬂuorescence determined in a Perkin-Elmer ﬂuorescence
spectrophotometer at Ex488/Em530 nm. nPo0.05 compared with control; #Po0.05 compared with AA group, (N¼3).
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macroautophagy is protective against ethanol/CYP2E1 elevation of
ROS, fatty liver and liver injury or promotes these responses by the
liver to ethanol.
Inhibition of autophagy by treatment with 3-MA increased binge
ethanol-induced hepatotoxicity, steatosis and oxidant stress in wild
type mice and CYP2E1 knockin mice to as much greater extent than
in CYP2E1 knockout mice [39]. Stimulation of autophagy by
rapamycin blunted the binge ethanol toxicity [13,39]. Inhibition
of autophagy in HepG2 E47 cells increased ethanol-induced fat
accumulation and oxidant stress to a greater extent than that
found in C34 cells which do not express CYP2E1 [37]. These results
suggest that, autophagy is protective against ethanol-CYP2E1-
dependent toxicity and fat accumulation.
The current report extended the previous studies of autophagy
being protective against ethanol/CYP2E1-dependent steatosis to
other CYP2E1-dependent toxicity models. We evaluated the toxi-
city of AA, a decline in hepatoprotective GSH and CCl4 since these
have been either implicated in ethanol liver toxicity or are widely
Fig. 4. Effects of AA, BSO or CCl4 on autophagy-related proteins and CYP2E1. E47 cells were treated with AA, BSO or CCl4 in the presence or absence of 3-MA or rapamycin for
48 h as described in the legend to Fig. 1. (A) LC3 levels were evaluated by immunoblots and the LC3-II/LC3-I ratio calculated (n, #Po0.05 compared with AA, BSO or CCl4
alone groups, N¼3). (B) and (C) Levels of autophagy regulation proteins p62 and Beclin-1 were determined by immunoblots and their relative ratios with β-actin are listed
under the blots (n, #Po0.05 compared with AA or BSO or CCl4 alone groups, N¼3). (D) The effect of AA, BSO or CCl4 with or without treatment with 3-MA or rapamycin on
protein levels of CYP2E1.
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used to produce liver injury and ﬁbrosis. All three were previously
found to produce greater toxicity in the E47 cells compared to the
C34 cells [43,44,54]. Inhibition of autophagy elevated the toxicity
of the three agents in the E47 cells but not the C34 cells. The mode
of elevated cell death was primarily necrotic, although there was a
small increase in apoptotic cell death. Atg 7 siRNA, but not
scrambled siRNA, elevated AA toxicity analogous to the chemical
inhibition of autophagy by 3-MA. Rapamycin, in contrast to 3-MA
or Atg 7 siRNA decreased the toxicity and the necrosis of AA or BSO
or CCl4 in the E47 cells, consistent with autophagy being protective
against CYP2E1-dependent toxicity. The cytoprotective effects of
autophagy may be mediated, in part, by negative regulation of
apoptosis [73,74], e.g. 50 mM ethanol decreased levels of Beclin-1
and LC3 II in HepG2 cells and activation of autophagy by globular
adiponectin or rapamycin attenuated the ethanol-induced apop-
tosis by modulation of levels of Bax [75]. Most of the toxicity
produced by AA or BSO or CCl4 in the E47 cells was necrotic
although some apoptosis was also observed. Rapamycin, while
lowering necrosis, increased the apoptosis induced by AA and CCl4,
perhaps a reﬂection of the crosstalk between apoptosis and
autophagy.
The increased loss of cell viability produced by AA, BSO or CCl4
in the E47 cells when autophagy was inhibited was associated
with an increase in ROS. The increase in ROS is likely important for
the increase in toxicity as the antioxidant NAC blunted the toxicity
of AA alone and the elevated toxicity of AA in the presence of
Atg 7 siRNA under conditions in which NAC also blocked the
increase in mitochondrial ROS production produced by AA and AA
plus Atg 7 siRNA. This would be consistent with CYP2E1 as an
effective promoter of ROS, especially in the presence of AA or BSO
or CCl4. There may be several explanations as to why ROS
production by the toxins is elevated when autophagy is inhibited
Fig. 5. Autophagy modulates AA, BSO and CCl4 induced mitochondrial dysfunction. E47 cells were treated with AA, BSO or CCl4 with or without 3-MA or rapamycin for 48 h
and mitochondria were freshly prepared. Mitochondrial membrane swelling (A–C) was evaluated by determining the decrease in absorbance at 540 nm after the addition of
100 mM CaCl2. (A) AA; (B) BSO; (C) CCl4; (D) Cellular ATP levels (nPo0.05 compared with control; #Po0.05 compared with AA, BSO or CCl4 alone, N¼4). (E): Levels of
cytochrome c in the cytosol. Numbers below the blots refer to the cytosolic cytochrome c/β-actin ratio as determined from blots (a) and (b) (nPo0.05 compared with AA, BSO
or CCl4 alone, N¼3). Blot (c) is an immunoblot of mitochondrial SOD2 to ensure that the cytosolic preparation was not contaminated with mitochondria. (F) levels of
cytochrome c in the mitochondria. Numbers below the blots refer to the cytochrome c/COX IV ratio as determined from blots (a) and (b). (nPo0.05 compared with AA, CCl4
alone, N¼3.) Blot (c) shows levels of SOD2 in the mitochondrial preparation.
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e.g. decreased lipophagy and mitophagy with the subsequent
accumulation of oxidized lipids and damaged mitochondria. While
there are reports that ROS can increase autophagy as a protective
mechanism, there are also reports that elevated ROS can inhibit
autophagy [76–78]. ROS-induction of autophagy has been impli-
cated in cell survival but also cell death [79].
With respect to damaged mitochondria, AA or BSO or CCl4
produced toxicity to the mitochondria as evidenced by enhanced
Fig. 6. Inhibition of autophagy promotes AA, BSO and CCl4 induced mitochondrial ROS formation. (A) (a), E47 cells were treated with AA, BSO or CCl4 in the absence or
presence of 3-MA or rapamycin for 48 h, and cells were then incubated with 5 mM MitoSox for 30 min. The red-stained mitochondria were observed under a ﬂuorescence
microscope (magniﬁcation 100). (b), Cells were also re-suspended in 1PBS and the intensity of ﬂuorescence was determined in a Perkin-Elmer ﬂuorescence
spectrophotometer at Ex510/Em580 nm. nPo0.05 compared with control; #, &Po0.05 compared with AA, BSO or CCl4 alone respectively, N¼3; (B) (a), Genetic knockdown
of Atg 7 with Atg 7 siRNA increases Mitosox ﬂuorescence in E47 cells treated with AA for 48 h while treatment with NAC decreases Mitosox ﬂuorescence. (Magniﬁcation
100). (b), Determination of the ﬂuorescence intensity as described in (a), nPo0.05 compared with control; #Po0.05 compared with AA; &Po0.05 compared with AA, Atg 7
siRNA, N¼3.
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calcium-induced energized swelling, decreased levels of cellular
ATP, and release of cytochrome c from the mitochondria to the
cytosol. This mitochondrial dysfunction was elevated when autop-
hagy was inhibited. This damage to the mitochondria is likely
linked to elevated oxidative stress as the three toxins increased
Mitosox ﬂuorescence and these increases were further elevated
when autophagy was inhibited by 3-MA but decreased by rapa-
mycin. In addition, NAC blunted the increases in Mitosox ﬂuores-
cence produced by AA and the further increase produced by the
Atg 7 siRNA.
MAP kinases have been implicated in the regulation of autop-
hagy [80–82]. p38MAPK appears to have a dual role acting as a
Fig. 7. Inhibition of autophagy promotes AA activation of p38 MAPK and JNK. E47 cells were treated with 3-MA or rapamycin in the presence or absence of AA (45 mM) for 6,
12, 24 and 48 h. Cell lysates were prepared and immunoblots were carried out to determine the time course activation of p38 MAPK (A and B) or JNK (C and D). The ratio of
pp38 MAPK/p38 MAPK is listed at the bottoms of blots A and B (nPo0.05 compared with AA alone or with control, N¼3). The ratios of p-JNK/JNK (JNK 1 and JNK 2) are listed
at the bottom of blots C and D (nPo0.05 compared with AA alone, N¼3).
D. Wu, A.I. Cederbaum / Redox Biology 1 (2013) 552–565 561
positive or negative regulator of autophagy depending on condi-
tions, cell type, cell stress [82,83]. For example, activation of
p38MAPK in colon cancer cells induced cell survival autophagy
[83] and p38 MAPK activation in hepatic stellate cells increased
autophagy followed by stellate cell activation [84]. Activation of
p38 MAPK induced autophagy in astrocytes and melanoma cells
[85] and glucose induced autophagy under starvation conditions
by a p38 MAPK mechanism independent of mTOR or AMPK in NIH
3T3 cells [82]. On the other hand, there are reports that activation
of p38 MAPK decreased autophagy in colon cancer cells [86]. The
maturation steps of autophagy were decreased by activation of
p38 MAPK [87]. Activation of p38MAPK impaired autophagy in
hepatocytes [88], as well as in macrophages with a resultant
increase in accumulation of cholesterol esters and foam cell
formation [89]. Possible mechanisms for the inhibition of autop-
hagy by p38 MAPK activation might be due to decreased expres-
sion of ULK 1 [89] or increased binding of p62 to activated
p38MAPK [81]. JNK MAPK also regulates autophagy [90] e.g. JNK
was required for enhanced autophagy and cell survival in response
to 4-hydroxynonenal treatment [91]. Menadione-induced ROS
formation decreased autophagy in hepatocytes and this led to
over activation of JNK/c-jun signaling and subsequent hepatocyte
toxicity [92].
Previous studies showed that activation of p38 MAPK played an
important role in the toxicity produced when AA or BSO or TNFα
were added to the E47 cells [43–45]. The increase in liver injury
when either LPS or TNFα were administered to CYP2E1 induced
mice was associated with activation of p38 and JNK MAPK and
could be blunted by inhibitors of these MAPK [55,93,94]. A JNK
inhibitor blocked the decrease in autophagy produced by binge
ethanol treatment [38]. These results led to studies as to whether
p38 MAPK or JNK (no effects on ERK were observed) were
activated by AA, especially when autophagy was inhibited, and if
so, whether such activation played a role in the enhanced toxicity
by AA when autophagy was inhibited. AA activated p38 MAPK
about 2-fold after 24 and 48 h of incubation and inhibition of
autophagy further elevated the activation of p38 MAPK by AA an
additional 2-fold. In addition, an early activation of p38 MAPK at
6 h was observed when AA plus 3-MA were added together.
Stimulation of autophagy with rapamycin decreased the AA alone
Fig. 8. A p38MAPK inhibitor and a JNK inhibitor decrease 3-MA enhanced AA cytotoxicity. E47 cells were treated with 45 mM AA plus 3-MA or rapamycin in the presence or
absence of SB203580 (5 mM) or SP600125 (2.5 mM) for 24 and 48 h. (A): cell viability was determined by a MTT assay (n, #Po0.05 compared with AA plus 3-MA for 24 or
48 h, N¼3). (B) and (C): Effects of SB201580 and SP600125 on the activation of p38 MAPK. The inhibition of p38 MAPK by SB203580 at 24 h (B) and 48 h (C) was determined
by Immunoblot analyses. The pp38 MAPK/p38 MAPK ratios are listed underneath the blots (nPo0.05 compared with AA plus 3MA, n¼3). The inhibition of JNK activation by
SP600125 at 24 h (D) and 48 h (E) was determined by immunoblot analyses. The ratios of pJNK/JNK are listed at the bottom of the blots. (nnPo0.05 compared with AA plus
rapamycin; nPo0.05 compared with AA plus 3-MA, n¼3).
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activation of p38 MAPK. AA alone did not activate JNK but when
autophagy was inhibited, AA activated JNK after 24 and 48 h of
incubation. The elevated activation of p38 MAPK and JNK by AA
when autophagy was inhibited contributes to the increased
toxicity by AA when autophagy was inhibited as inhibitors of
p38 MAPK and JNK largely (24 h) or partially (48 h) blunted the
toxicity. We did not study the combined effects of SB and SP. The
role of these MAPK in the toxicity by BSO or CCl4 and the
potentiated toxicity of these agents when autophagy is inhibited
remains to be determined. These results implicate p38 MAPK and
JNK as contributing to the elevated toxicity by AA in the E47 cells
when autophagy is inhibited. While the crosstalk between MAPK
and autophagy requires further study, we speculate that the
decrease in autophagy results in an increase in ROS which then
results in an increase in, or an earlier activation of, or a more
sustained activation of p38 MAPK or JNK. A scheme summarizing
these results is depicted in Fig. 9. Increased production of ROS by
cells expressing CYP2E1 occurs when GSH levels are lowered after
treatment with BSO or when polyunsaturated fatty acids such as
AA undergo lipid peroxidation or when halogenated hydrocarbon
such as CCl4 are metabolized to CCl3 radical. ROS can activate p38
and JNK MAPK and activated p38 MAPK or JNK can further elevate
ROS as there is a reciprocal relationship between ROS and
activated MAPK. The combination of ROS and activated MAPK
leads to mitochondrial dysfunction. Inhibition of autophagy ele-
vates lipid accumulation (decreased lipophagy), lipid peroxidation
and ROS while decreasing removal of damaged mitochondria by
mitophagy thereby promoting the CYP2E1 toxicity. NAC is protec-
tive against this toxicity via its antioxidant activity against ROS.
In summary, autophagy is protective against toxicity of several
agents known to be either directly activated by CYP2E1 (e.g. CCl4)
or whose toxicity is elevated after induction of CYP2E1 (e.g. AA,
BSO). Autophagy has also been shown to protect against CYP2E1-
dependent toxicity of acute ethanol in vivo [38,39] and chronic
ethanol treatment (Wu and Cederbaum, unpublished observa-
tions). Since CYP2E1 plays an important role in the liver injury
produced by ethanol, many chemicals and procarcinogens and
under various pathophysiological conditions, efforts to maintain
and/or activate autophagy would likely be beneﬁcial and impor-
tant for therapeutic considerations.
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